Posterior Reversible Encephalopathy Syndrome Associated with Tacrolimus in Cardiac Transplantation

Background. Neurological complications occur between 50 and 70% of patients with heart transplantation, including cerebrovascular events, infections, seizures, encephalopathy, and neurotoxicity due to pharmacological immunosuppression. Mortality associated with cerebrovascular complications is 7.5%...

Full description

Saved in:
Bibliographic Details
Main Authors: Julián Alejandro Rivillas, Stephania Galindo-Coral, Francisco Arias-Mora, Juan David Lopez-Ponce de Leon, Noel Alberto Florez-Alarcón, Pastor Olaya-Rojas, Juan Esteban Gomez-Mesa
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Case Reports in Cardiology
Online Access:http://dx.doi.org/10.1155/2021/9998205
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560689283072000
author Julián Alejandro Rivillas
Stephania Galindo-Coral
Francisco Arias-Mora
Juan David Lopez-Ponce de Leon
Noel Alberto Florez-Alarcón
Pastor Olaya-Rojas
Juan Esteban Gomez-Mesa
author_facet Julián Alejandro Rivillas
Stephania Galindo-Coral
Francisco Arias-Mora
Juan David Lopez-Ponce de Leon
Noel Alberto Florez-Alarcón
Pastor Olaya-Rojas
Juan Esteban Gomez-Mesa
author_sort Julián Alejandro Rivillas
collection DOAJ
description Background. Neurological complications occur between 50 and 70% of patients with heart transplantation, including cerebrovascular events, infections, seizures, encephalopathy, and neurotoxicity due to pharmacological immunosuppression. Mortality associated with cerebrovascular complications is 7.5% in the first 30 days and up to 5.3% after the first month and up to the first year after transplantation. Case Reports. Three heart-transplanted patients (2 men and 1 woman) treated with tacrolimus were identified. They presented with posterior reversible encephalopathy syndrome on days 5, 6, and 58 posttransplantation, respectively. In these reported cases, no sequelae were observed at 6 months follow-up. Conclusions. Posterior reversible encephalopathy syndrome as a neurological complication in patients with HT occurred early after the procedure. Early diagnosis and treatment might reduce the risk of serious complications and mortality.
format Article
id doaj-art-b020d71928cb4dfb81d15f16a8b17f4b
institution Kabale University
issn 2090-6404
2090-6412
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Case Reports in Cardiology
spelling doaj-art-b020d71928cb4dfb81d15f16a8b17f4b2025-02-03T01:26:59ZengWileyCase Reports in Cardiology2090-64042090-64122021-01-01202110.1155/2021/99982059998205Posterior Reversible Encephalopathy Syndrome Associated with Tacrolimus in Cardiac TransplantationJulián Alejandro Rivillas0Stephania Galindo-Coral1Francisco Arias-Mora2Juan David Lopez-Ponce de Leon3Noel Alberto Florez-Alarcón4Pastor Olaya-Rojas5Juan Esteban Gomez-Mesa6Resident of Neurology, Universidad Icesi, Cali, ColombiaCardiology Department, Fundación Valle del Lili Hospital Universitario, Cali, ColombiaNeurology Department, Fundación Valle del Lili Hospital Universitario, Cali, ColombiaCardiology Department, Fundación Valle del Lili Hospital Universitario, Cali, ColombiaCardiology Department, Fundación Valle del Lili Hospital Universitario, Cali, ColombiaCardiology Department, Fundación Valle del Lili Hospital Universitario, Cali, ColombiaCardiology Department, Fundación Valle del Lili Hospital Universitario, Cali, ColombiaBackground. Neurological complications occur between 50 and 70% of patients with heart transplantation, including cerebrovascular events, infections, seizures, encephalopathy, and neurotoxicity due to pharmacological immunosuppression. Mortality associated with cerebrovascular complications is 7.5% in the first 30 days and up to 5.3% after the first month and up to the first year after transplantation. Case Reports. Three heart-transplanted patients (2 men and 1 woman) treated with tacrolimus were identified. They presented with posterior reversible encephalopathy syndrome on days 5, 6, and 58 posttransplantation, respectively. In these reported cases, no sequelae were observed at 6 months follow-up. Conclusions. Posterior reversible encephalopathy syndrome as a neurological complication in patients with HT occurred early after the procedure. Early diagnosis and treatment might reduce the risk of serious complications and mortality.http://dx.doi.org/10.1155/2021/9998205
spellingShingle Julián Alejandro Rivillas
Stephania Galindo-Coral
Francisco Arias-Mora
Juan David Lopez-Ponce de Leon
Noel Alberto Florez-Alarcón
Pastor Olaya-Rojas
Juan Esteban Gomez-Mesa
Posterior Reversible Encephalopathy Syndrome Associated with Tacrolimus in Cardiac Transplantation
Case Reports in Cardiology
title Posterior Reversible Encephalopathy Syndrome Associated with Tacrolimus in Cardiac Transplantation
title_full Posterior Reversible Encephalopathy Syndrome Associated with Tacrolimus in Cardiac Transplantation
title_fullStr Posterior Reversible Encephalopathy Syndrome Associated with Tacrolimus in Cardiac Transplantation
title_full_unstemmed Posterior Reversible Encephalopathy Syndrome Associated with Tacrolimus in Cardiac Transplantation
title_short Posterior Reversible Encephalopathy Syndrome Associated with Tacrolimus in Cardiac Transplantation
title_sort posterior reversible encephalopathy syndrome associated with tacrolimus in cardiac transplantation
url http://dx.doi.org/10.1155/2021/9998205
work_keys_str_mv AT julianalejandrorivillas posteriorreversibleencephalopathysyndromeassociatedwithtacrolimusincardiactransplantation
AT stephaniagalindocoral posteriorreversibleencephalopathysyndromeassociatedwithtacrolimusincardiactransplantation
AT franciscoariasmora posteriorreversibleencephalopathysyndromeassociatedwithtacrolimusincardiactransplantation
AT juandavidlopezponcedeleon posteriorreversibleencephalopathysyndromeassociatedwithtacrolimusincardiactransplantation
AT noelalbertoflorezalarcon posteriorreversibleencephalopathysyndromeassociatedwithtacrolimusincardiactransplantation
AT pastorolayarojas posteriorreversibleencephalopathysyndromeassociatedwithtacrolimusincardiactransplantation
AT juanestebangomezmesa posteriorreversibleencephalopathysyndromeassociatedwithtacrolimusincardiactransplantation